{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6fv1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10071","date":"2022-12-02T17:00:00.000Z","role":"Approver"},{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10071","date":"2022-12-02T19:58:17.388Z","role":"Publisher"}],"evidence":[{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:aec0e37a-facf-497e-a6f7-a8ad8f1b0238","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:f5b23c70-c2fb-4497-a0c5-1a1ce10312b3","type":"Finding","demonstrates":{"id":"cg:GeneExpressionB"},"dc:description":"The EIF2AK4 protein is detected in smooth muscle cells of the vessel wall and interstitial tissue and in macrophages in control lungs. A similar pattern of expression was observed in a lung from a patient affected with PVOD that did not have EIF2AK4 mutation. However, there was no detected expression of EIF2AK4 in the lung from patient IV-3 of family PVOD5, who carries the homozygous mutation encoding p.Lys190Glufs*8.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/24292273","type":"dc:BibliographicResource","dc:abstract":"Pulmonary veno-occlusive disease (PVOD) is a rare and devastating cause of pulmonary hypertension that is characterized histologically by widespread fibrous intimal proliferation of septal veins and preseptal venules and is frequently associated with pulmonary capillary dilatation and proliferation. PVOD is categorized into a separate pulmonary arterial hypertension-related group in the current classification of pulmonary hypertension. PVOD presents either sporadically or as familial cases with a seemingly recessive mode of transmission. Using whole-exome sequencing, we detected recessive mutations in EIF2AK4 (also called GCN2) that cosegregated with PVOD in all 13 families studied. We also found biallelic EIF2AK4 mutations in 5 of 20 histologically confirmed sporadic cases of PVOD. All mutations, either in a homozygous or compound-heterozygous state, disrupted the function of the gene. These findings point to EIF2AK4 as the major gene that is linked to PVOD development and contribute toward an understanding of the complex genetic architecture of pulmonary hypertension.","dc:creator":"Eyries M","dc:date":"2014","dc:title":"EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension."},"rdfs:label":"Immunohistochemical staining with an EIF2AK4 antibody"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5},{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:f321ce6a-8673-4a62-b501-0899ab849037_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f321ce6a-8673-4a62-b501-0899ab849037","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":19,"allele":[{"id":"cggv:41157b75-1f97-4b23-803a-93370328d2c2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1153dup (p.Val385GlyfsTer30)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7473724"}},{"id":"cggv:073e189d-974e-4b70-8dad-fc54e983a987","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3766C>T (p.Arg1256Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150736"}}],"detectionMethod":"Whole Exome Sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Diagnosed Pulmonary capillary hemangiomatosis.","sex":"Male","variant":[{"id":"cggv:21ea1a90-440c-45b7-bfcd-bd4acefd7cf1_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:073e189d-974e-4b70-8dad-fc54e983a987"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/24135949","type":"dc:BibliographicResource","dc:abstract":"Pulmonary capillary hemangiomatosis (PCH) is a rare disease of capillary proliferation of unknown cause and with a high mortality. Families with multiple affected individuals with PCH suggest a heritable cause although the genetic etiology remains unknown.","dc:creator":"Best DH","dc:date":"2014","dc:title":"EIF2AK4 mutations in pulmonary capillary hemangiomatosis."}},{"id":"cggv:9f73a650-0447-4547-aae0-ad59365a4b84_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:41157b75-1f97-4b23-803a-93370328d2c2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24135949"}],"rdfs:label":"Family 1: Member II.1"},{"id":"cggv:9f73a650-0447-4547-aae0-ad59365a4b84","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:9f73a650-0447-4547-aae0-ad59365a4b84_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found with a minor allele frequency in the East Asian population at a rate of 0.00005118 (1/19538) in gnomAD."},{"id":"cggv:21ea1a90-440c-45b7-bfcd-bd4acefd7cf1","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:21ea1a90-440c-45b7-bfcd-bd4acefd7cf1_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the European (Non-Finnish) population at a rate of 0.0001856 (21/113166) in gnomAD."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:bb21f7ae-1894-4a22-9424-42cb4b70929c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:bb21f7ae-1894-4a22-9424-42cb4b70929c","type":"Proband","allele":{"id":"cggv:3bd29fb1-1e90-4012-b8ac-c855074c2fb1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3605A>T (p.His1202Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391696023"}},"detectionMethod":"Next generation sequencing using 100-150 base pair paired-end sequencing was performed on DNA libraries created from genomic DNA using Illumina HiSeq 2500 and HiSeq X (Illumina Inc, San Diego, USA).","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:aa684815-bd82-412f-9c49-e4b088e01ba5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3bd29fb1-1e90-4012-b8ac-c855074c2fb1"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/28972005","type":"dc:BibliographicResource","dc:abstract":"Pulmonary arterial hypertension (PAH) is a rare disease with an emerging genetic basis. Heterozygous mutations in the gene encoding the bone morphogenetic protein receptor type 2 (","dc:creator":"Hadinnapola C","dc:date":"2017","dc:title":"Phenotypic Characterization of "}},"rdfs:label":"PAH proband 4 Hadinnapola et al."},{"id":"cggv:aa684815-bd82-412f-9c49-e4b088e01ba5","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:aa684815-bd82-412f-9c49-e4b088e01ba5_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Absent from gnomAD from all subpopulations. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:65aae400-9fb4-42c5-a783-c17592a87adb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:65aae400-9fb4-42c5-a783-c17592a87adb","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":11,"allele":{"id":"cggv:d5e10714-b628-49fd-8728-447037b75e8b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1928T>G (p.Leu643Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7473885"}},"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Considered the diagnosis to be highly likely on the basis of clinical and paraclinical data","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:29288c5b-d9e5-4cea-87ad-d27278a6e34a_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d5e10714-b628-49fd-8728-447037b75e8b"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD13 IV-3 "},{"id":"cggv:29288c5b-d9e5-4cea-87ad-d27278a6e34a","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:29288c5b-d9e5-4cea-87ad-d27278a6e34a_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Found in the Latino population at a rate of 0.00008778 (3/34178) in gnomAD."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:10b4559a-ee1f-44db-a2ab-068425f30bb6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:10b4559a-ee1f-44db-a2ab-068425f30bb6","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":37,"allele":[{"id":"cggv:becd42a0-c69a-4bdf-837f-cd1e3539966b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.4728+1_4728+13delinsTTCT","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645293890"}},{"id":"cggv:6e1532e5-b3e9-4a4c-9988-62b7c40f9e5d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3448C>T (p.Arg1150Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150738"}}],"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Considered the diagnosis to be highly likely on the basis of clinical and paraclinical data","phenotypes":"obo:HP_0006518","sex":"Female","variant":[{"id":"cggv:d2e7e349-94be-4474-be0d-c6319f4b01fc_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:6e1532e5-b3e9-4a4c-9988-62b7c40f9e5d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},{"id":"cggv:3a889acd-62e7-4df5-a3c0-facbc831a5a7_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:becd42a0-c69a-4bdf-837f-cd1e3539966b"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"}],"rdfs:label":"PVOD11 II-1"},{"id":"cggv:3a889acd-62e7-4df5-a3c0-facbc831a5a7","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:3a889acd-62e7-4df5-a3c0-facbc831a5a7_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Absent from gnomAD. "},{"id":"cggv:d2e7e349-94be-4474-be0d-c6319f4b01fc","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d2e7e349-94be-4474-be0d-c6319f4b01fc_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the South Asian population at a rate of 0.00003377 (1/29610) in gnomAD. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ee8f1b4d-fae6-4458-839d-49468eddba93_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ee8f1b4d-fae6-4458-839d-49468eddba93","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":50,"allele":[{"id":"cggv:b5d67399-98a0-489a-958e-8d5624c192ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.354_355del (p.Cys118TrpfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645293889"}},{"id":"cggv:b414a3df-c52f-4b34-9684-6cb7cda997de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1554-4C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7473804"}}],"detectionMethod":"Whole Exome sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Diagnosed as having pulmonary capillary hemangiomatosis. Extensive precapillary proliferation with moderated venous involvement in explanted lung samples. Confirmed PVOD\ndiagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member.","phenotypes":"obo:HP_0006518","sex":"Female","variant":[{"id":"cggv:d7e00629-fcaa-4f65-a82a-0e76a101ccf7_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b414a3df-c52f-4b34-9684-6cb7cda997de"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},{"id":"cggv:e1c8cd3c-2016-4d1b-ae1c-d4f6e3489cdf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b5d67399-98a0-489a-958e-8d5624c192ec"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"}],"rdfs:label":"PVOD 1 II.2"},{"id":"cggv:e1c8cd3c-2016-4d1b-ae1c-d4f6e3489cdf","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:e1c8cd3c-2016-4d1b-ae1c-d4f6e3489cdf_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD. "},{"id":"cggv:d7e00629-fcaa-4f65-a82a-0e76a101ccf7","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:d7e00629-fcaa-4f65-a82a-0e76a101ccf7_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Found in the European (non-Finnish) population at a rate of 0.00001766 (2/113228)\t."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:49d60d48-8fb8-4fb0-8f59-50db2cad145e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:49d60d48-8fb8-4fb0-8f59-50db2cad145e","type":"Proband","allele":{"id":"cggv:e172d286-545e-47f7-9aa6-ef3831b77676","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1795G>C (p.Gly599Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391682936"}},"detectionMethod":"Next generation sequencing using 100-150 base pair paired-end sequencing was performed on DNA libraries created from genomic DNA using Illumina HiSeq 2500 and HiSeq X (Illumina Inc, San Diego, USA).","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:0f5d9785-a06c-4ff1-ab9a-86f414da3d36_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e172d286-545e-47f7-9aa6-ef3831b77676"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28972005"},"rdfs:label":"PAH proband 3 Hadinnapola et al. "},{"id":"cggv:0f5d9785-a06c-4ff1-ab9a-86f414da3d36","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:0f5d9785-a06c-4ff1-ab9a-86f414da3d36_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Found in the South Asian population at a rate of 0.00003268 (1/30596) in gnomAD. Found in another individual with PAH in the cohort."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e5fb6595-0ef6-41c2-8434-82ef51588dee_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e5fb6595-0ef6-41c2-8434-82ef51588dee","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":36,"allele":{"id":"cggv:f63a2d44-6703-4e20-9edf-63d036242cce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.4065+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391675580"}},"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Considered PVOD diagnosis to be highly likely on the basis of clinical and paraclinical data.","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:751ef805-8128-4e29-86da-7da683fca1e5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f63a2d44-6703-4e20-9edf-63d036242cce"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD9 II-5"},{"id":"cggv:751ef805-8128-4e29-86da-7da683fca1e5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:751ef805-8128-4e29-86da-7da683fca1e5_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD in all subpopulaitons. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e5c398f8-bfda-4ba0-9ed5-a6a31ee877c3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e5c398f8-bfda-4ba0-9ed5-a6a31ee877c3","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":26,"allele":{"id":"cggv:6f37c444-1071-4432-97b0-8ab7abb0a726","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3159G>A (p.Lys1053=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA489967989"}},"detectionMethod":"Whole Exome Sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Confirmed the PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:27a27169-02d4-4d7e-a070-f5958c25e140_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:6f37c444-1071-4432-97b0-8ab7abb0a726"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD6 III-2"},{"id":"cggv:27a27169-02d4-4d7e-a070-f5958c25e140","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:27a27169-02d4-4d7e-a070-f5958c25e140_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Found in the European (non-Finnish) population at a rate of 0.000008882 (1/112588). Pathogenic by ClinVar."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:311ed831-15c1-4835-b5b1-b70e2527c6fe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:311ed831-15c1-4835-b5b1-b70e2527c6fe","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":23,"allele":[{"id":"cggv:f0df6c77-0726-496b-b633-81fe6c28f7ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.2136_2139dup (p.Ser714HisfsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7473924"}},{"id":"cggv:b5855aab-8153-46b4-88a1-1c340dbdabeb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.745C>T (p.Arg249Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7473620"}}],"detectionMethod":"Whole Exome Sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"We confirmed the PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member.","phenotypes":"obo:HP_0006518","sex":"Female","variant":[{"id":"cggv:c85178a4-eb2e-4fd7-88b6-8fb558d11c54_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b5855aab-8153-46b4-88a1-1c340dbdabeb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},{"id":"cggv:7f0479d8-deae-4f6f-aea4-e4929a44abcb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f0df6c77-0726-496b-b633-81fe6c28f7ce"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"}],"rdfs:label":"PVOD3 II.2"},{"id":"cggv:c85178a4-eb2e-4fd7-88b6-8fb558d11c54","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:c85178a4-eb2e-4fd7-88b6-8fb558d11c54_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the European (non-Finnish) population at a rate of 0.00009469 (12/126730)."},{"id":"cggv:7f0479d8-deae-4f6f-aea4-e4929a44abcb","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:7f0479d8-deae-4f6f-aea4-e4929a44abcb_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the Euroean (non-Finnish) population at a rate of 0.00002951 (3/101664)."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a8c18a25-e9c9-4ee9-b28d-4ef81b84af64_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a8c18a25-e9c9-4ee9-b28d-4ef81b84af64","type":"Proband","allele":{"id":"cggv:fca746ca-8854-4cb2-babb-0afd9122d54c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3344C>T (p.Pro1115Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7474312"}},"detectionMethod":"SNP-array-based homozygosity mapping ","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Early lung transplantation","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:65d50da1-61fc-44b4-994e-49a854a93aaf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:fca746ca-8854-4cb2-babb-0afd9122d54c"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25512148","type":"dc:BibliographicResource","dc:abstract":"Pulmonary arterial hypertension (PAH) is a pathological condition characterized by a persistent and progressive elevation of pulmonary vascular resistance with devastating consequences if untreated. In the past recent years, several genes have been related to PAH, however, the molecular defect remains unknown in a significant proportion of patients with familial PAH (âˆ¼20%). During the past few years, we have observed that PAH shows a particular behavior in Iberian Gypsies, with more aggressive course and frequently affecting multiple members of the same family. We studied five Gypsy families in whom at least one individual from each family developed a severe form of PAH and in whom no mutation had been identified in the common genes. We applied SNP-array-based homozygosity mapping in three families and obtained, among others, one of which included the gene EIF2AK4, recently reported in patients with PAH from group-1' pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH). Subsequently, we sequenced EIF2AK4 and found a homozygous mutation in all five families: c.3344C>T(p.P1115L). The majority of our patients required early lung transplantation. Hence, this mutation appeared with a more severe phenotype than previously reported for other EIF2AK4 mutations. The finding of this novel mutation is important for genetic counseling and calculation of population recurrence risks.","dc:creator":"Tenorio J","dc:date":"2015","dc:title":"A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies."}},"rdfs:label":"Proband Tenorio"},{"id":"cggv:65d50da1-61fc-44b4-994e-49a854a93aaf","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:65d50da1-61fc-44b4-994e-49a854a93aaf_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Found in the Latino poplation at a rate of 0.0001159 (4/34520)\t"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:161ba1c1-2ad5-4677-b661-99e7f2ad704b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:161ba1c1-2ad5-4677-b661-99e7f2ad704b","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":23,"allele":{"id":"cggv:c33f803b-b1b6-4222-aabb-2189b76a9607","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.2319+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391685800"}},"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"PVOD diagnosis confirmed histologically after lung transplantation or lung biopsy in at\nleast one family member ","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:33442572-983f-42ad-a61b-0e699519a214_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c33f803b-b1b6-4222-aabb-2189b76a9607"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD2 II.2"},{"id":"cggv:33442572-983f-42ad-a61b-0e699519a214","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:33442572-983f-42ad-a61b-0e699519a214_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:57cf824f-7a06-4fbb-b2ad-3587010303c9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:57cf824f-7a06-4fbb-b2ad-3587010303c9","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":44,"allele":[{"id":"cggv:318fe51e-ad99-489c-8c9d-92354a6ce3bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1387C>T (p.Arg463Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA149758"}},{"id":"cggv:08bcf028-42f4-4c7c-a09d-d95f90fb52fc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3244C>T (p.Gln1082Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391694477"}}],"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Confirmed the PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member.","phenotypes":"obo:HP_0006518","sex":"Male","variant":[{"id":"cggv:fef25064-4a73-4c69-b779-5ffd60efc0a0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:08bcf028-42f4-4c7c-a09d-d95f90fb52fc"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},{"id":"cggv:6082a978-8910-4e4f-89bd-a3dd79a303a9_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:318fe51e-ad99-489c-8c9d-92354a6ce3bb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"}],"rdfs:label":"PVOD12 II-1"},{"id":"cggv:fef25064-4a73-4c69-b779-5ffd60efc0a0","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:fef25064-4a73-4c69-b779-5ffd60efc0a0_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD in all subpopulations."},{"id":"cggv:6082a978-8910-4e4f-89bd-a3dd79a303a9","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:6082a978-8910-4e4f-89bd-a3dd79a303a9_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the European (Non-Finnish) population at a rate of 0.000008827 (1/113288) in gnomAD"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:dac885ae-d20a-4279-85ba-6f158a95fa08_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:dac885ae-d20a-4279-85ba-6f158a95fa08","type":"Proband","allele":{"id":"cggv:024c5592-b615-423e-859a-ab8c93916e0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1159_1160del (p.Leu387CysfsTer27)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915946544"}},"detectionMethod":"Next generation sequencing using 100-150 base pair paired-end sequencing was performed on DNA libraries created from genomic DNA using Illumina HiSeq 2500 and HiSeq X (Illumina Inc, San Diego, USA).","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:19a7cae9-d186-45ab-a2a8-062dda43c642_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:024c5592-b615-423e-859a-ab8c93916e0d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28972005"},"rdfs:label":" PAH Proband 2 Hadinnapola et al. "},{"id":"cggv:19a7cae9-d186-45ab-a2a8-062dda43c642","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:19a7cae9-d186-45ab-a2a8-062dda43c642_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:6ee337d8-3efa-4fdb-9907-8ad0a0c95059_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:6ee337d8-3efa-4fdb-9907-8ad0a0c95059","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":20,"allele":{"id":"cggv:6f649b9a-76a8-4ffa-82c0-6c681f445729","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.567dup (p.Lys190GlufsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA149754"}},"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Confirmed the PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member. ","phenotypes":"obo:HP_0006518","sex":"Female","variant":{"id":"cggv:39f6d9a5-f4c2-410e-976b-cefb2e2289fe_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:6f649b9a-76a8-4ffa-82c0-6c681f445729"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD5 IV.3"},{"id":"cggv:39f6d9a5-f4c2-410e-976b-cefb2e2289fe","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:39f6d9a5-f4c2-410e-976b-cefb2e2289fe_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD in all populations. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:420d9a5f-a650-4ecf-a272-91aa4ab24e74_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:420d9a5f-a650-4ecf-a272-91aa4ab24e74","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":32,"allele":{"id":"cggv:0eff0a0a-38ae-4e5f-ba28-e5e6ac66e69b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3406C>T (p.Arg1136Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA149755"}},"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Confirmed PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member. ","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:364ea726-532b-412c-9e6b-908452d52fce_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0eff0a0a-38ae-4e5f-ba28-e5e6ac66e69b"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD7 II.1"},{"id":"cggv:364ea726-532b-412c-9e6b-908452d52fce","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:364ea726-532b-412c-9e6b-908452d52fce_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Variant is found in the European (non-Finnish) population at a rate of 0.000008942 (1/111836)."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:6a703fe5-d4b5-41dd-8523-6c3ced592f9b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:6a703fe5-d4b5-41dd-8523-6c3ced592f9b","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":20,"allele":[{"id":"cggv:0108c748-f015-427d-83ae-3c5eba2b25d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3802C>T (p.Gln1268Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA149752"}},{"id":"cggv:c76e617c-a317-48dd-95b8-cee0d3235d58","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1392del (p.Arg465ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA149751"}}],"detectionMethod":"Whole Exome Sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Authors considered PVOD diagnosis to be highly likely on the basis of clinical and paraclinical data.","phenotypes":"obo:HP_0006518","sex":"Male","variant":[{"id":"cggv:58a2f57a-063c-468e-bc05-a0cc9d696386_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c76e617c-a317-48dd-95b8-cee0d3235d58"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},{"id":"cggv:3253654e-58c3-4e2b-bf93-0e2a5a3a2e34_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0108c748-f015-427d-83ae-3c5eba2b25d3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"}],"rdfs:label":"PVOD4 II.2"},{"id":"cggv:3253654e-58c3-4e2b-bf93-0e2a5a3a2e34","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:3253654e-58c3-4e2b-bf93-0e2a5a3a2e34_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD in all populations. "},{"id":"cggv:58a2f57a-063c-468e-bc05-a0cc9d696386","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:58a2f57a-063c-468e-bc05-a0cc9d696386_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the European (Non-Finnish) population at a rate of 0.00006215 (8/128712)."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:c2e7eb5e-9b6d-438e-bd53-e582b4e92291_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:c2e7eb5e-9b6d-438e-bd53-e582b4e92291","type":"Proband","allele":{"id":"cggv:1a32d1b6-6fa1-4897-8dc5-45ab5c6061c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.3097C>T (p.Gln1033Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7474231"}},"detectionMethod":"Next generation sequencing using 100-150 base pair paired-end sequencing was performed on DNA libraries created from genomic DNA using Illumina HiSeq 2500 and HiSeq X (Illumina Inc, San Diego, USA).","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:f46fc288-59a7-4c90-96ff-c2c7c7df1758_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1a32d1b6-6fa1-4897-8dc5-45ab5c6061c0"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28972005"},"rdfs:label":"PAH proband 4 Hadinnapola et al."},{"id":"cggv:f46fc288-59a7-4c90-96ff-c2c7c7df1758","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:f46fc288-59a7-4c90-96ff-c2c7c7df1758_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the South Asian population at a rate of 0.00003268 (1/30596) in gnomAD. Found in another individual with PAH in the cohort. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:19203a7c-d5c2-4f6d-b4ed-c5cd59772091_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:19203a7c-d5c2-4f6d-b4ed-c5cd59772091","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":26,"allele":{"id":"cggv:feae41d7-cda5-418a-a712-e4fb4ecf65fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.1754G>A (p.Arg585Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA149757"}},"detectionMethod":"Whole Exome sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Confirmed PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member ","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:3b8cbfee-6f56-480e-ac3a-c410f94081ba_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:feae41d7-cda5-418a-a712-e4fb4ecf65fa"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD8 III.3"},{"id":"cggv:3b8cbfee-6f56-480e-ac3a-c410f94081ba","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:3b8cbfee-6f56-480e-ac3a-c410f94081ba_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Found in the East Asian population at a rate of 0.00005562 (1/17978) in gnomAD."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ac6070e8-59d6-4c93-9db8-3f008c903fe7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ac6070e8-59d6-4c93-9db8-3f008c903fe7","type":"Proband","allele":{"id":"cggv:c0972658-1410-4fec-ba8f-66b748a1ac4b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.4392dup (p.Lys1465Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA617212620"}},"detectionMethod":"Next generation sequencing using 100-150 base pair paired-end sequencing was performed on DNA libraries created from genomic DNA using Illumina HiSeq 2500 and HiSeq X (Illumina Inc, San Diego, USA).","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:2c0af1ef-164a-48ed-a7bb-b86a723dc94e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c0972658-1410-4fec-ba8f-66b748a1ac4b"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28972005"},"rdfs:label":"PAH proband 5 Hadinnapola et al."},{"id":"cggv:2c0af1ef-164a-48ed-a7bb-b86a723dc94e","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:2c0af1ef-164a-48ed-a7bb-b86a723dc94e_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the European (Non-Finnish) population at a rate of 0.00001555 (2/128582) in gnomAD."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:1f6207ea-ee97-4aef-9314-a799c5a4d9e8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:1f6207ea-ee97-4aef-9314-a799c5a4d9e8","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":19,"allele":{"id":"cggv:318fe51e-ad99-489c-8c9d-92354a6ce3bb"},"detectionMethod":"Whole Exome Sequencing ","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Confirmed the PVOD diagnosis histologically after lung transplantation or lung biopsy in at\nleast one family member ","phenotypes":"obo:HP_0006518","sex":"Male","variant":{"id":"cggv:8a5b947a-bfee-47e7-bbd2-82651444bdc5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:318fe51e-ad99-489c-8c9d-92354a6ce3bb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24292273"},"rdfs:label":"PVOD10 II-1"},{"id":"cggv:8a5b947a-bfee-47e7-bbd2-82651444bdc5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8a5b947a-bfee-47e7-bbd2-82651444bdc5_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Found in the European (Non-Finnish) popuation at a rate of 0.000008827 (1/113288) in gnomAD."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:95702112-631b-447c-b4c1-2b8bc28dc527_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:95702112-631b-447c-b4c1-2b8bc28dc527","type":"Proband","allele":{"id":"cggv:9977947e-d166-4a84-8870-787af0b26a06","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001013703.4(EIF2AK4):c.281dup (p.Asn94LysfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915946543"}},"detectionMethod":"Next generation sequencing using 100-150 base pair paired-end sequencing was performed on DNA libraries created from genomic DNA using Illumina HiSeq 2500 and HiSeq X.","firstTestingMethod":"Next generation sequencing panels","phenotypes":"obo:HP_0002092","sex":"UnknownEthnicity","variant":{"id":"cggv:9c05d5ee-0466-4d8a-9fcf-4d795cd8619d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9977947e-d166-4a84-8870-787af0b26a06"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28972005"},"rdfs:label":"PAH Proband 1 Hadinnapola et al. "},{"id":"cggv:9c05d5ee-0466-4d8a-9fcf-4d795cd8619d","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:9c05d5ee-0466-4d8a-9fcf-4d795cd8619d_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Absent from gnomAD. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5381,"specifiedBy":"GeneValidityCriteria9","strengthScore":12.5,"subject":{"id":"cggv:2995bafc-7ff7-4b1c-be1e-1576e70844cd","type":"GeneValidityProposition","disease":"obo:MONDO_0018554","gene":"hgnc:19687","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"EIF2AK4 was first reported in relation to autosomal recessive pulmonary veno-occlusive disease (PVOD) in 2014 (Eyries et al., PMID:24292273). More than 22 distinct variants (e.g. missense, in-frame indel, nonsense, frameshift, etc) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level genetic data and protein expression in lung.\n\nSummary of case-level data: 43.4 points  (max. 12 points)\nvariants in this gene have been reported in more than 21 probands (PMIDs: 24292273, 24135949, 25512148, 28972005, and others). Summary of experimental evidence: 0.5 points.\n \nThe evidence supporting this gene-disease relationship has been replicated over more than 5 years. In summary, EIF2AK4 is definitively associated with autosomal recessive pulmonary veno-occlusive disease/capillary haemangiomatosis (PVOD/PCH) which is frequently misdiagnosed as pulmonary arterial hypertension. This classification was approved by the ClinGen PH Gene Curation Expert Panel on August 30, 2022 (SOP v9).","dc:isVersionOf":{"id":"cggv:9d20386c-ad1a-4c88-9f43-4ca3cedbfd6f"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}